TH9507 in Patients With HIV-Associated Lipodystrophy
NCT00123253
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
412
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Lipodystrophy
Interventions
DRUG:
TH9507
Sponsor
Theratechnologies